Gamida Cell Ltd. (GMDA) Prices 12.9M Share Offering at $1.55/sh

Go back to Gamida Cell Ltd. (GMDA) Prices 12.9M Share Offering at $1.55/sh

Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares

September 28, 2022 12:08 AM EDT

BOSTON--(BUSINESS WIRE)-- Gamida Cell Ltd. (Nasdaq: GMDA), the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced the pricing of a follow-on public offering of 12,905,000 of its ordinary shares at a public offering price of $1.55 per share for aggregate gross proceeds of $20 million, before deducting underwriting discounts and commissions and estimated offering expenses. In addition, Gamida Cell has granted the underwriters a 30-day option to purchase up to an additional 1,935,750 ordinary shares at the public offering price, less the... More